Navigation

guaifenesin (Mucinex, Bidex 400, Organidin NR)

 

Classes: Expectorants

Dosing and uses of Mucinex, Bidex 400 (guaifenesin)

 

Adult dosage forms and strengths

tablet

  • 200mg
  • 400mg

tablet, extended-release

  • 600mg
  • 1200mg

oral syrup

  • 100mg/5mL

liquid

  • 100mg/5mL
  • 200mg/5mL

packet

  • 50mg
  • 100mg

 

Cough

100-400 mg PO q4hr; not to exceed 2.4 g/day

Extended release: 1-2 tablets (600-1200 mg) PO q12hr; not to exceed 4 tablets/24 hr (2.4 g/day)

 

Administration

Swallow extended-release tablets whole; do not chew or crush

 

Pediatric dosage forms and strengths

tablet

  • 200mg
  • 400mg

tablet, extended-release

  • 600mg
  • 1200mg

oral syrup

  • 100mg/5mL

liquid

  • 100mg/5mL
  • 200mg/5mL

packet

  • 50mg
  • 100mg

 

Cough

6 months to 2 years: 25-50 mg q4hr; not to exceed 300 mg/day

2-6 years: 50-100 mg PO q4hr; not to exceed 600 mg/day

6-12 years: 100-200 mg PO q4hr; not to exceed 1.2 g/day

>12 years

  • 100-400 mg PO q4hr; not to exceed 2.4 g/day, OR
  • 1-2 extended-release tablets (600-1200 mg) PO q12hr; not to exceed 4 tablets/24 hr (2.4 g/day)

 

Mucinex, Bidex 400 (guaifenesin) adverse (side) effects

Frequency not defined

Dizziness

Drowsiness

Decreased uric acid levels

Stomach pain

Nausea

Vomiting

Headache

Rash

 

Postmarketing Reports

Kidney stone formation

 

Warnings

Contraindications

Hypersensitivity

 

Cautions

Often comes in combos; check brand name/other constituents

Some products may contain phenylalanine

When using as self-medication in chronic or persistent coughs, notify health-care practitioner if no improvement within 7 days

 

Pregnancy and lactation

Pregnancy category: C

Lactation: Excretion in milk unknown; use with caution

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Mucinex, Bidex 400 (guaifenesin)

Mechanism of action

Reduces viscosity of secretions by increasing amount of respiratory tract fluid and irritates gastric mucosa

 

Absorption

Onset: 30 min

Duration: 4-6 hr

 

Metabolism

Liver

Metabolite: b-(2-methoxyphenoxy) lactic acid

 

Elimination

Half-life: 1 hr

Excretion: Urine